Report Company Directory
- Tougher Regulation Fails to Halt M&A Leaks as Number of Leaked Deals Rises by BusinessWire
- Ford Equity US Rating and Forecast Report by Ford Equity Research
- INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Intralinks Holdings, Inc. And Encourages Shareholders To Contact The Firm For Additional Information by BusinessWire
- SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Intralinks Holdings, Inc. And Encourages Investors To Contact The Firm For Additional Information by BusinessWire
- INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of IntraLinks Holdings, Inc. to Synchronoss Technologies, Inc. for $13 Per Share is Fair to Shareholders -- IL by BusinessWire
- INTRALINKS HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Synchronoss Technologies, Inc. May be Unfair to Shareholders by BusinessWire
- INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Whether the Sale of IntraLinks Holdings, Inc. to Synchronoss Technologies, Inc. for $13 Per Share is Fair to Shareholders -- IL by BusinessWire
- INTRALINKS HOLDINGS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout by BusinessWire
- Intralinks Makes Further Strategic Investment in Europe by BusinessWire
- 2016 Likely to Be Record Year for M&A Announcements by BusinessWire
- INVEST SECURITIES - INTRASENSE : S1 préoccupant, des objectifs 2026 trop exigeants - NEUTRE, OC 0,24€ vs 0,37€ by Invest Securities
- INVEST SECURITIES - INTRASENSE: Une année 2024 cruciale, les yeux rivés sur Liflow® - NEUTRE, OC 0,37€ vs 0,35€ by Invest Securities
- INVEST SECURITIES – INTRASENSE : La chine s'endort - NEUTRE vs ACHAT, OC 0,35€ vs 0,48€ by Invest Securities
- INVEST SECURITIES - TOP PICKS MEDTECH : Dans la continuité de 2023 by Invest Securities
- INVEST SECURITIES - TOP PICKS MEDTECH : Dans la continuité de 2023 by Invest Securities
- Top picks Biotech : La prudence devra être de mise by Invest Securities
- Top picks Biotech : La prudence devra être de mise by Invest Securities
- INVEST SECURITIES – INTRASENSE : S1 conforme mais encore trop peu savoureux - NEUTRE, OC 0,48€ vs 0,53€ by Invest Securities
- INVEST SECURITIES – INTRASENSE : Potentiel consommé, une pause avant le S1 - NEUTRE vs ACHAT, OC 0,53€ by Invest Securities
- INVEST SECURITIES - INTRASENSE : Opération satisfaisante mais insuffisante - ACHAT, OC 0,53€ (vs 0,74€) by Invest Securities